Bottom line
What is APIMX's expense ratio?
APIMX's expense ratio is 0.79%, or about $79 a year on every $10,000 invested. That is more expensive than 80% of short-term bond funds we track (median 0.47%). This share class also charges a front-end sales load of up to 2.25%, taken from your investment when you buy.
Updated May 27, 2026
APIMX fee table
| Net expense ratio | 0.79% |
|---|---|
| Gross expense ratio | 1% |
| Management fee | 0.7% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.3% |
| Fee waiver / reimbursement | -0.21% |
| Max front-end sales load | 2.25% |
| Max deferred sales charge | 0.5% |
Source: Fund prospectus fee table, filed May 27, 2026
What APIMX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| APIMX | $304 | $516 | $745 | $1,403 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.79% expense ratio costs roughly $44,600 in lost growth, versus about $27,300 for the median short-term bond fund (0.47%).